Theragen Etex Co.,Ltd. (KOSDAQ:066700)

South Korea · Delayed Price · Currency is KRW

3,130.00

+5.00 (0.16%)

At close: Apr 17, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Business			203.31B	170.81B	144.46B	123.47B	119.99B
Pharmaceutical Business Growth			19.03%	18.23%	17.01%	2.90%	23.79%
Health Care and Genome Analysis Business			20.99B	24.47B	23.00B	20.40B	19.45B
Health Care and Genome Analysis Business Growth			-14.22%	6.41%	12.72%	4.88%	-10.38%
Consolidation Reconciliation Journal Entry			-1.24B	-1.90B	-896.67M	-847.33M	-1.36B
Suspended Business			-6.59B	-2.61B	-	-	-
Total			216.47B	190.77B	166.57B	143.02B	138.08B
Total Growth			13.47%	14.53%	16.46%	3.58%	17.54%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			213.90B	188.08B	164.00B	141.73B	136.54B
South Korea Growth			13.72%	14.69%	15.71%	3.80%	18.70%
Overseas			2.57B	2.68B	2.57B	1.29B	1.54B
Overseas Growth			-4.18%	4.55%	99.01%	-16.46%	-
Total			216.47B	190.77B	166.57B	143.02B	138.08B
Total Growth			13.47%	14.53%	16.46%	3.58%	17.54%

Source: S&P Global Market Intelligence.